Michael Gold to Biomarkers, Tumor
This is a "connection" page, showing publications Michael Gold has written about Biomarkers, Tumor.
Connection Strength
0.323
-
Chromosomal gains measured in cytology samples from women with abnormal cervical cancer screening results. Gynecol Oncol. 2013 Sep; 130(3):595-600.
Score: 0.088
-
Accuracy of cervical specimens obtained for biomarker studies in women with CIN3. Gynecol Oncol. 2009 Dec; 115(3):493-6.
Score: 0.068
-
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. Gynecol Oncol. 2005 Oct; 99(1):50-7.
Score: 0.052
-
Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns. Diagn Mol Pathol. 2005 Jun; 14(2):59-64.
Score: 0.050
-
Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014 Jan; 33(1):64-73.
Score: 0.023
-
Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer. 2009 Feb 15; 124(4):964-9.
Score: 0.016
-
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):113-20.
Score: 0.016
-
Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma. J Natl Cancer Inst. 2001 Apr 04; 93(7):516-25.
Score: 0.009